Pacific Biosciences Of Stock Price Prediction
| PACB Stock | USD 1.36 0.11 7.48% |
Oversold Vs Overbought
35
Oversold | Overbought |
Pacific Biosciences stock price prediction is an act of determining the future value of Pacific Biosciences shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pacific Biosciences' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Pacific Biosciences and does not consider all of the tangible or intangible factors available from Pacific Biosciences' fundamental data. We analyze noise-free headlines and recent hype associated with Pacific Biosciences of, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Pacific Biosciences' stock price prediction:EPS Estimate Next Quarter (0.27) | EPS Estimate Current Year (1.02) | EPS Estimate Next Year (0.82) | Wall Street Target Price 6.08 | EPS Estimate Current Quarter (0.28) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pacific Biosciences based on different types of headlines from major news networks to social media. The Pacific stock price prediction module provides an analysis of price elasticity to changes in media outlook on Pacific Biosciences over a specific investment horizon. Using Pacific Biosciences hype-based prediction, you can estimate the value of Pacific Biosciences of from the perspective of Pacific Biosciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pacific Biosciences using Pacific Biosciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pacific using crowd psychology based on the activity and movement of Pacific Biosciences' stock price.
Pacific Biosciences Short Interest
A significant increase or decrease in Pacific Biosciences' short interest from the previous month could be a good indicator of investor sentiment towards Pacific. Short interest can provide insight into the potential direction of Pacific Biosciences stock and how bullish or bearish investors feel about the market overall. An investor who is long Pacific Biosciences may also wish to track short interest. As short interest increases, investors should be becoming more worried about Pacific Biosciences and may potentially protect profits, hedge Pacific Biosciences with its derivative instruments, or be ready for some potential downside.
200 Day MA 7.8785 | Short Percent 0.2029 | Short Ratio 5.76 | Shares Short Prior Month 49 M | 50 Day MA 3.917 |
Pacific Biosciences Hype to Price Pattern
Investor biases related to Pacific Biosciences' public news can be used to forecast risks associated with an investment in Pacific. The trend in average sentiment can be used to explain how an investor holding Pacific can time the market purely based on public headlines and social activities around Pacific Biosciences of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pacific Biosciences' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pacific Biosciences.
Pacific Biosciences Implied Volatility | 154.91 |
Pacific Biosciences' implied volatility exposes the market's sentiment of Pacific Biosciences of stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pacific Biosciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pacific Biosciences stock will not fluctuate a lot when Pacific Biosciences' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Pacific Biosciences. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pacific Biosciences to buy its stock at a price that has no basis in reality. In that case, they are not buying Pacific because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pacific Biosciences after-hype prediction price | USD 1.53 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pacific |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pacific Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pacific Biosciences After-Hype Price Prediction Density Analysis
As far as predicting the price of Pacific Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pacific Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pacific Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pacific Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Pacific Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pacific Biosciences' historical news coverage. Pacific Biosciences' after-hype downside and upside margins for the prediction period are 0.08 and 9.59, respectively. We have considered Pacific Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pacific Biosciences is very risky at this time. Analysis and calculation of next after-hype price of Pacific Biosciences is based on 3 months time horizon.
Pacific Biosciences Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pacific Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pacific Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pacific Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.18 | 8.06 | 0.17 | 2.83 | 9 Events / Month | 4 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.36 | 1.53 | 12.50 |
|
Pacific Biosciences Hype Timeline
Pacific Biosciences is at this time traded for 1.36. The entity has historical hype elasticity of 0.17, and average elasticity to hype of competition of -2.83. Pacific is forecasted to increase in value after the next headline, with the price projected to jump to 1.53 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 12.5%, whereas the daily expected return is at this time at -2.18%. The volatility of related hype on Pacific Biosciences is about 621.91%, with the expected price after the next announcement by competition of -1.47. The company currently holds 933.93 M in liabilities with Debt to Equity (D/E) ratio of 1.51, which is about average as compared to similar companies. Pacific Biosciences has a current ratio of 10.97, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Pacific Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pacific Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pacific Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pacific to invest in growth at high rates of return. When we think about Pacific Biosciences' use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next forecasted press release will be in about 9 days. Check out Pacific Biosciences Basic Forecasting Models to cross-verify your projections.Pacific Biosciences Related Hype Analysis
Having access to credible news sources related to Pacific Biosciences' direct competition is more important than ever and may enhance your ability to predict Pacific Biosciences' future price movements. Getting to know how Pacific Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pacific Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LH | Laboratory of | 0.52 | 11 per month | 0.00 | (0.18) | 1.48 | (2.03) | 5.31 | |
| IDXX | IDEXX Laboratories | (5.93) | 11 per month | 0.00 | (0.11) | 2.37 | (2.31) | 11.55 | |
| RVTY | Revvity | (1.69) | 12 per month | 0.00 | (0.08) | 2.18 | (3.32) | 8.66 | |
| CDNA | Caredx Inc | (0.04) | 8 per month | 0.00 | (0.03) | 9.53 | (6.93) | 27.30 | |
| GH | Guardant Health | 0.66 | 12 per month | 0.00 | (0.11) | 5.84 | (7.29) | 22.73 |
Pacific Biosciences Additional Predictive Modules
Most predictive techniques to examine Pacific price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pacific using various technical indicators. When you analyze Pacific charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pacific Biosciences Predictive Indicators
The successful prediction of Pacific Biosciences stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pacific Biosciences of, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pacific Biosciences based on analysis of Pacific Biosciences hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pacific Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pacific Biosciences's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 6.51 | 6.59 | 10.63 | 6.38 | Days Of Inventory On Hand | 125.31 | 231.98 | 129.15 | 157.86 |
Story Coverage note for Pacific Biosciences
The number of cover stories for Pacific Biosciences depends on current market conditions and Pacific Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pacific Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pacific Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Pacific Biosciences Short Properties
Pacific Biosciences' future price predictability will typically decrease when Pacific Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pacific Biosciences of often depends not only on the future outlook of the potential Pacific Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pacific Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 253.6 M | |
| Cash And Short Term Investments | 631.7 M |
Check out Pacific Biosciences Basic Forecasting Models to cross-verify your projections. Note that the Pacific Biosciences information on this page should be used as a complementary analysis to other Pacific Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Pacific Stock analysis
When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Pacific Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.21) | Revenue Per Share 0.791 | Quarterly Revenue Growth 1.133 | Return On Assets (0.11) | Return On Equity (0.49) |
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.